상단영역
본문영역
All articles 목록 ( 총 : 41 )
기사목록 보기 형태
-
BeiGene's anticancer drug Brukinsa to get expanded insurance coverage
-
Korea's health insurance panel denies coverage for new cancer drugs
-
All eyes of patients and drugmakers are on reimbursement of Enhertu
-
Korea to launch MSD's 15-valent PCV vaccine in national immunization program
-
Korean government stalls access to PARP inhibitors for prostate cancer patients
-
Biliary tract cancer patients can now use Imfinzi at their own expense
-
Balversa, 1st FGFR inhibitor for bladder cancer, will be available in Korea soon
-
Jassen's delay in Korean launch of Balversa sparks speculation
-
GSK's Shingrix vaccine linked to higher risk of ‘ophthalmic zoster’ recurrence: study
-
After many twists and turns, Gilead's HIV drug Truvada survives in Korea
-
New products stage sales war in ulcerative colitis treatment market
-
BeiGene applies for insurance benefits for esophageal cancer drug Tevimbra